The vaccine against COVID-19 "Sputnik M" (Gam-COVID-Vak-M) was registered in Kazakhstan

On February 19, 2022, the Committee of Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan issued a temporary registration certificate for the drug "Gum-COVID-Vak-M" for a period of 8 months.
Gam-COVID-Vac-M is a combined vector vaccine for the prevention of coronavirus infection caused by the SARS-CoV-2 virus, solution for intramuscular administration, component I-0.5 ml/dose+ component II-0.5 ml/dose, manufactured in the Russian Federation.
The vaccine was registered on the basis of the Minutes of the meeting of the Interdepartmental Commission on Preventing the Occurrence and Spread of coronavirus infection in the territory of the Republic of Kazakhstan dated February 10, 2022 and the conclusion of the RSE on the PCV "National Center for Expertise of Medicines and Medical Devices" KM and FC of the Ministry of Health of the Republic of Kazakhstan dated February 17, 2022.
Sputnik M is designed for teenagers aged 12-17 years.
It should be noted that the difference between Sputnik M and Sputnik V is a five-fold reduced concentration of adenovirus particles, due to which adolescent immunity is subjected to less stress compared to the use of adult dosage.